These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 12956433

  • 1. Phage therapy: a reappraisal of bacteriophages as antibiotics.
    Inal JM.
    Arch Immunol Ther Exp (Warsz); 2003; 51(4):237-44. PubMed ID: 12956433
    [Abstract] [Full Text] [Related]

  • 2. [Bacteriophages as antibacterial agents].
    Shasha SM, Sharon N, Inbar M.
    Harefuah; 2004 Feb; 143(2):121-5, 166. PubMed ID: 15143702
    [Abstract] [Full Text] [Related]

  • 3. [Phagotherapy in terms of bacteriophage genetics: hopes, perspectives, safety, limitations].
    Krylov VN.
    Genetika; 2001 Jul; 37(7):869-87. PubMed ID: 11558226
    [Abstract] [Full Text] [Related]

  • 4. Bacteriophage therapy in children: facts and prospects.
    Fortuna W, Miedzybrodzki R, Weber-Dabrowska B, Górski A.
    Med Sci Monit; 2008 Aug; 14(8):RA126-32. PubMed ID: 18668009
    [Abstract] [Full Text] [Related]

  • 5. The prospect for bacteriophage therapy in Western medicine.
    Merril CR, Scholl D, Adhya SL.
    Nat Rev Drug Discov; 2003 Jun; 2(6):489-97. PubMed ID: 12776223
    [Abstract] [Full Text] [Related]

  • 6. Phage therapy: past history and future prospects.
    Carlton RM.
    Arch Immunol Ther Exp (Warsz); 1999 Jun; 47(5):267-74. PubMed ID: 10604231
    [Abstract] [Full Text] [Related]

  • 7. [Phage lytic enzymes--new hope in battle against bacterial infections].
    Niczyporuk JS, Bartoszcze M.
    Przegl Epidemiol; 2007 Jun; 61(4):713-21. PubMed ID: 18572503
    [Abstract] [Full Text] [Related]

  • 8. Bacteriophages as potential new therapeutics to replace or supplement antibiotics.
    Kutateladze M, Adamia R.
    Trends Biotechnol; 2010 Dec; 28(12):591-5. PubMed ID: 20810181
    [Abstract] [Full Text] [Related]

  • 9. Bacteriophages: an appraisal of their role in the treatment of bacterial infections.
    Hanlon GW.
    Int J Antimicrob Agents; 2007 Aug; 30(2):118-28. PubMed ID: 17566713
    [Abstract] [Full Text] [Related]

  • 10. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
    Burrowes B, Harper DR, Anderson J, McConville M, Enright MC.
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):775-85. PubMed ID: 21905786
    [Abstract] [Full Text] [Related]

  • 11. Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches.
    Chanishvili N.
    Adv Virus Res; 2012 Sep; 83():3-40. PubMed ID: 22748807
    [Abstract] [Full Text] [Related]

  • 12. The perspectives of the application of phage therapy in chronic bacterial prostatitis.
    Letkiewicz S, Międzybrodzki R, Kłak M, Jończyk E, Weber-Dąbrowska B, Górski A.
    FEMS Immunol Med Microbiol; 2010 Nov; 60(2):99-112. PubMed ID: 20698884
    [Abstract] [Full Text] [Related]

  • 13. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM, Ritter K, Horz HP.
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [Abstract] [Full Text] [Related]

  • 14. Reinventing phage therapy: are the parts greater than the sum?
    Fischetti VA, Nelson D, Schuch R.
    Nat Biotechnol; 2006 Dec; 24(12):1508-11. PubMed ID: 17160051
    [Abstract] [Full Text] [Related]

  • 15. Bacteriophage applications: where are we now?
    Monk AB, Rees CD, Barrow P, Hagens S, Harper DR.
    Lett Appl Microbiol; 2010 Oct; 51(4):363-9. PubMed ID: 20796209
    [Abstract] [Full Text] [Related]

  • 16. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.
    Golkar Z, Bagasra O, Pace DG.
    J Infect Dev Ctries; 2014 Feb 13; 8(2):129-36. PubMed ID: 24518621
    [Abstract] [Full Text] [Related]

  • 17. Phage-inspired antibiotics?
    Projan S.
    Nat Biotechnol; 2004 Feb 13; 22(2):167-8. PubMed ID: 14755287
    [No Abstract] [Full Text] [Related]

  • 18. Phage therapy.
    Housby JN, Mann NH.
    Drug Discov Today; 2009 Jun 13; 14(11-12):536-40. PubMed ID: 19508915
    [Abstract] [Full Text] [Related]

  • 19. [New perspectives of the phage therapy].
    Eyer L, Pantůcek R, Růzicková V, Doskar J.
    Klin Mikrobiol Infekc Lek; 2007 Dec 13; 13(6):231-5. PubMed ID: 18320502
    [Abstract] [Full Text] [Related]

  • 20. Antibacterial application of engineered bacteriophage nanomedicines: antibody-targeted, chloramphenicol prodrug loaded bacteriophages for inhibiting the growth of Staphylococcus aureus bacteria.
    Vaks L, Benhar I.
    Methods Mol Biol; 2011 Dec 13; 726():187-206. PubMed ID: 21424451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.